APO Research
Talk to an analyst

APO RESEARCH · REPORT

Combined Polio Vaccine

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Combined Polio Vaccine Industry Growth and Trends Forecast to 2032

26 December 202597 pages

Choose your research edition.

Industry ResearchCombined Polio Vaccine Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Combined Polio Vaccine Industry Growth and Trends Forecast to 203297 pages · $3,450 USDMarket StructureGlobal Combined Polio Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Combined Polio Vaccine Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Combined Polio Vaccine Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Combined Polio Vaccine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Combined Polio Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Combined Polio Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Combined Polio Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Combined Polio Vaccine include Sanofi, Merck & Co., Inc., Panacea Biotec Ltd., Mitsubishi Chemical Group Corp., Meiji Holdings Co., Ltd. and Boryung Corp., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Combined Polio Vaccine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Combined Polio Vaccine market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Combined Polio Vaccine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Combined Polio Vaccine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Combined Polio Vaccine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Combined Polio Vaccine Market by Company

Sanofi

Merck & Co., Inc.

Panacea Biotec Ltd.

Mitsubishi Chemical Group Corp.

Meiji Holdings Co., Ltd.

Boryung Corp.

Combined Polio Vaccine Segment by Type

1 Dose

3 Doses

4 Doses

Combined Polio Vaccine Segment by Application

Hospital

Clinic

Others

Combined Polio Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Combined Polio Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Combined Polio Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Combined Polio Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Combined Polio Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Combined Polio Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 1 Dose Table 2. Major Company of 3 Doses Table 3. Major Company of 4 Doses Table 4. Global Combined Polio Vaccine Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Combined Polio Vaccine Sales by Type (2021-2026) & (K Units) Table 6. Global Combined Polio Vaccine Sales Market Share in Volume by Type (2021-2026) Table 7. Global Combined Polio Vaccine Sales by Type (2021-2026) & (US$ Million) Table 8. Global Combined Polio Vaccine Sales Market Share in Value by Type (2021-2026) Table 9. Global Combined Polio Vaccine Price by Type (2021-2026) & (US$/Unit) Table 10. Global Combined Polio Vaccine Sales by Type (2027-2032) & (K Units) Table 11. Global Combined Polio Vaccine Sales Market Share in Volume by Type (2027-2032) Table 12. Global Combined Polio Vaccine Sales by Type (2027-2032) & (US$ Million) Table 13. Global Combined Polio Vaccine Sales Market Share in Value by Type (2027-2032) Table 14. Global Combined Polio Vaccine Price by Type (2027-2032) & (US$/Unit) Table 15. North America Combined Polio Vaccine Sales by Type (2021-2026) & (K Units) Table 16. North America Combined Polio Vaccine Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Combined Polio Vaccine Sales by Type (2021-2026) & (K Units) Table 18. Europe Combined Polio Vaccine Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Combined Polio Vaccine Sales by Type (2021-2026) & (K Units) Table 20. Asia-Pacific Combined Polio Vaccine Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Combined Polio Vaccine Sales by Type (2021-2026) & (K Units) Table 22. Latin America Combined Polio Vaccine Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Combined Polio Vaccine Sales by Type (2021-2026) & (K Units) Table 24. Middle East and Africa Combined Polio Vaccine Sales by Type (2021-2026) & (US$ Million) Table 25. Combined Polio Vaccine Industry Trends Table 26. Combined Polio Vaccine Industry Drivers Table 27. Combined Polio Vaccine Industry Opportunities and Challenges Table 28. Combined Polio Vaccine Industry Restraints Table 29. Global Combined Polio Vaccine Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Combined Polio Vaccine Revenue Market Share by Company (2021-2026) Table 31. Global Combined Polio Vaccine Sales by Company (2021-2026) & (K Units) Table 32. Global Combined Polio Vaccine Sales Share by Company (2021-2026) Table 33. Global Combined Polio Vaccine Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Combined Polio Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Combined Polio Vaccine Major Company Production Sites and Headquarters Table 36. Global Combined Polio Vaccine Company, Product Type & Application Table 37. Global Combined Polio Vaccine Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Combined Polio Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Combined Polio Vaccine Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Combined Polio Vaccine Sales by Region (2021-2026) & (K Units) Table 42. Global Combined Polio Vaccine Sales Market Share in Volume by Region (2021-2026) Table 43. Global Combined Polio Vaccine Sales by Region (2021-2026) & (US$ Million) Table 44. Global Combined Polio Vaccine Sales Market Share in Value by Region (2021-2026) Table 45. Global Combined Polio Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Combined Polio Vaccine Sales by Region (2027-2032) & (K Units) Table 47. Global Combined Polio Vaccine Sales Market Share in Volume by Region (2027-2032) Table 48. Global Combined Polio Vaccine Sales by Region (2027-2032) & (US$ Million) Table 49. Global Combined Polio Vaccine Sales Market Share in Value by Region (2027-2032) Table 50. Global Combined Polio Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Combined Polio Vaccine Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Combined Polio Vaccine Sales by Application (2021-2026) & (K Units) Table 53. Global Combined Polio Vaccine Sales Market Share in Volume by Application (2021-2026) Table 54. Global Combined Polio Vaccine Sales by Application (2021-2026) & (US$ Million) Table 55. Global Combined Polio Vaccine Sales Market Share in Value by Application (2021-2026) Table 56. Global Combined Polio Vaccine Price by Application (2021-2026) & (US$/Unit) Table 57. Global Combined Polio Vaccine Sales by Application (2027-2032) & (K Units) Table 58. Global Combined Polio Vaccine Sales Market Share in Volume by Application (2027-2032) Table 59. Global Combined Polio Vaccine Sales by Application (2027-2032) & (US$ Million) Table 60. Global Combined Polio Vaccine Sales Market Share in Value by Application (2027-2032) Table 61. Global Combined Polio Vaccine Price by Application (2027-2032) & (US$/Unit) Table 62. North America Combined Polio Vaccine Sales by Application (2021-2026) & (K Units) Table 63. North America Combined Polio Vaccine Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Combined Polio Vaccine Sales by Application (2021-2026) & (K Units) Table 65. Europe Combined Polio Vaccine Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Combined Polio Vaccine Sales by Application (2021-2026) & (K Units) Table 67. Asia-Pacific Combined Polio Vaccine Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Combined Polio Vaccine Sales by Application (2021-2026) & (K Units) Table 69. Latin America Combined Polio Vaccine Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Combined Polio Vaccine Sales by Application (2021-2026) & (K Units) Table 71. Middle East and Africa Combined Polio Vaccine Sales by Application (2021-2026) & (US$ Million) Table 72. Sanofi Company Information Table 73. Sanofi Business Overview Table 74. Sanofi Combined Polio Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Sanofi Combined Polio Vaccine Product Portfolio Table 76. Sanofi Recent Development Table 77. Merck & Co., Inc. Company Information Table 78. Merck & Co., Inc. Business Overview Table 79. Merck & Co., Inc. Combined Polio Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Merck & Co., Inc. Combined Polio Vaccine Product Portfolio Table 81. Merck & Co., Inc. Recent Development Table 82. Panacea Biotec Ltd. Company Information Table 83. Panacea Biotec Ltd. Business Overview Table 84. Panacea Biotec Ltd. Combined Polio Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Panacea Biotec Ltd. Combined Polio Vaccine Product Portfolio Table 86. Panacea Biotec Ltd. Recent Development Table 87. Mitsubishi Chemical Group Corp. Company Information Table 88. Mitsubishi Chemical Group Corp. Business Overview Table 89. Mitsubishi Chemical Group Corp. Combined Polio Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Mitsubishi Chemical Group Corp. Combined Polio Vaccine Product Portfolio Table 91. Mitsubishi Chemical Group Corp. Recent Development Table 92. Meiji Holdings Co., Ltd. Company Information Table 93. Meiji Holdings Co., Ltd. Business Overview Table 94. Meiji Holdings Co., Ltd. Combined Polio Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Meiji Holdings Co., Ltd. Combined Polio Vaccine Product Portfolio Table 96. Meiji Holdings Co., Ltd. Recent Development Table 97. Boryung Corp. Company Information Table 98. Boryung Corp. Business Overview Table 99. Boryung Corp. Combined Polio Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Boryung Corp. Combined Polio Vaccine Product Portfolio Table 101. Boryung Corp. Recent Development Table 102. North America Combined Polio Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 103. North America Combined Polio Vaccine Sales by Country (2021-2026) & (K Units) Table 104. North America Combined Polio Vaccine Sales Market Share by Country (2021-2026) Table 105. North America Combined Polio Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 106. North America Combined Polio Vaccine Sales Market Share Forecast by Country (2027-2032) Table 107. North America Combined Polio Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 108. North America Combined Polio Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 109. North America Combined Polio Vaccine Market Share by Country (2021-2026) Table 110. North America Combined Polio Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 111. North America Combined Polio Vaccine Market Share Forecast by Country (2027-2032) Table 112. Europe Combined Polio Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 113. Europe Combined Polio Vaccine Sales by Country (2021-2026) & (K Units) Table 114. Europe Combined Polio Vaccine Sales Market Share by Country (2021-2026) Table 115. Europe Combined Polio Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 116. Europe Combined Polio Vaccine Sales Market Share Forecast by Country (2027-2032) Table 117. Europe Combined Polio Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 118. Europe Combined Polio Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 119. Europe Combined Polio Vaccine Market Share by Country (2021-2026) Table 120. Europe Combined Polio Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 121. Europe Combined Polio Vaccine Market Share Forecast by Country (2027-2032) Table 122. Asia-Pacific Combined Polio Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 123. Asia-Pacific Combined Polio Vaccine Sales by Country (2021-2026) & (K Units) Table 124. Asia-Pacific Combined Polio Vaccine Sales Market Share by Country (2021-2026) Table 125. Asia-Pacific Combined Polio Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 126. Asia-Pacific Combined Polio Vaccine Sales Market Share Forecast by Country (2027-2032) Table 127. Asia-Pacific Combined Polio Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 128. Asia-Pacific Combined Polio Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 129. Asia-Pacific Combined Polio Vaccine Market Share by Country (2021-2026) Table 130. Asia-Pacific Combined Polio Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 131. Asia-Pacific Combined Polio Vaccine Market Share Forecast by Country (2027-2032) Table 132. Latin America Combined Polio Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 133. Latin America Combined Polio Vaccine Sales by Country (2021-2026) & (K Units) Table 134. Latin America Combined Polio Vaccine Sales Market Share by Country (2021-2026) Table 135. Latin America Combined Polio Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 136. Latin America Combined Polio Vaccine Sales Market Share Forecast by Country (2027-2032) Table 137. Latin America Combined Polio Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 138. Latin America Combined Polio Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 139. Latin America Combined Polio Vaccine Market Share by Country (2021-2026) Table 140. Latin America Combined Polio Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 141. Latin America Combined Polio Vaccine Market Share Forecast by Country (2027-2032) Table 142. Middle East and Africa Combined Polio Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 143. Middle East and Africa Combined Polio Vaccine Sales by Country (2021-2026) & (K Units) Table 144. Middle East and Africa Combined Polio Vaccine Sales Market Share by Country (2021-2026) Table 145. Middle East and Africa Combined Polio Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 146. Middle East and Africa Combined Polio Vaccine Sales Market Share Forecast by Country (2027-2032) Table 147. Middle East and Africa Combined Polio Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 148. Middle East and Africa Combined Polio Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 149. Middle East and Africa Combined Polio Vaccine Market Share by Country (2021-2026) Table 150. Middle East and Africa Combined Polio Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 151. Middle East and Africa Combined Polio Vaccine Market Share Forecast by Country (2027-2032) Table 152. Key Raw Materials Table 153. Raw Materials Key Suppliers Table 154. Combined Polio Vaccine Distributors List Table 155. Combined Polio Vaccine Customers List Table 156. Research Programs/Design for This Report Table 157. Authors List of This Report Table 158. Secondary Sources Table 159. Primary Sources List of Figures Figure 1. Combined Polio Vaccine Image Figure 2. Global Combined Polio Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Combined Polio Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global Combined Polio Vaccine Sales (2021-2032) & (K Units) Figure 5. 1 Dose Image Figure 6. Global 1 Dose Sales YoY Growth (2021-2032) & (K Units) Figure 7. 3 Doses Image Figure 8. Global 3 Doses Sales YoY Growth (2021-2032) & (K Units) Figure 9. 4 Doses Image Figure 10. Global 4 Doses Sales YoY Growth (2021-2032) & (K Units) Figure 11. Global Combined Polio Vaccine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Combined Polio Vaccine Market Share by Type 2025 VS 2032 Figure 13. North America Combined Polio Vaccine Sales Market Share in Volume by Type in 2025 Figure 14. North America Combined Polio Vaccine Sales Market Share in Value by Type in 2025 Figure 15. Europe Combined Polio Vaccine Sales Market Share in Volume by Type in 2025 Figure 16. Europe Combined Polio Vaccine Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Combined Polio Vaccine Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Combined Polio Vaccine Sales Market Share in Value by Type in 2025 Figure 19. Latin America Combined Polio Vaccine Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Combined Polio Vaccine Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Combined Polio Vaccine Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Combined Polio Vaccine Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Combined Polio Vaccine Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Hospital Image Figure 26. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 27. Clinic Image Figure 28. Global Clinic Sales YoY Growth (2021-2032) & (K Units) Figure 29. Others Image Figure 30. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 31. Global Combined Polio Vaccine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Combined Polio Vaccine Market Share by Application 2025 VS 2032 Figure 33. North America Combined Polio Vaccine Sales Market Share in Volume by Application in 2025 Figure 34. North America Combined Polio Vaccine Sales Market Share in Value by Application in 2025 Figure 35. Europe Combined Polio Vaccine Sales Market Share in Volume by Application in 2025 Figure 36. Europe Combined Polio Vaccine Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Combined Polio Vaccine Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Combined Polio Vaccine Sales Market Share in Value by Application in 2025 Figure 39. Latin America Combined Polio Vaccine Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Combined Polio Vaccine Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Combined Polio Vaccine Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Combined Polio Vaccine Sales Market Share in Value by Application in 2025 Figure 43. North America Combined Polio Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. North America Combined Polio Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Combined Polio Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Combined Polio Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Combined Polio Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Europe Combined Polio Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Combined Polio Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Combined Polio Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Combined Polio Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Asia-Pacific Combined Polio Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Combined Polio Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Combined Polio Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Combined Polio Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Latin America Combined Polio Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Combined Polio Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Combined Polio Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Combined Polio Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Middle East and Africa Combined Polio Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Combined Polio Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Combined Polio Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Combined Polio Vaccine Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Combined Polio Vaccine Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • 1 Dose
  • 3 Doses
  • 4 Doses
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Sanofi
  • Merck & Co., Inc.
  • Panacea Biotec Ltd.
  • Mitsubishi Chemical Group Corp.
  • Meiji Holdings Co., Ltd.
  • Boryung Corp.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Combined Polio Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Combined Polio Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Combined Polio Vaccine Market by Type
  6. 1.3.1 1 Dose
  7. 1.3.2 3 Doses
  8. 1.3.3 4 Doses
  9. 1.4 Global Combined Polio Vaccine Market Size by Type
  10. 1.4.1 Global Combined Polio Vaccine Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Combined Polio Vaccine Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Combined Polio Vaccine Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Combined Polio Vaccine Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Combined Polio Vaccine Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Combined Polio Vaccine Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Combined Polio Vaccine Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Combined Polio Vaccine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Combined Polio Vaccine Industry Trends
  2. 2.2 Combined Polio Vaccine Industry Drivers
  3. 2.3 Combined Polio Vaccine Industry Opportunities and Challenges
  4. 2.4 Combined Polio Vaccine Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Combined Polio Vaccine Revenue (2021-2026)
  2. 3.2 Global Top Players by Combined Polio Vaccine Sales (2021-2026)
  3. 3.3 Global Top Players by Combined Polio Vaccine Price (2021-2026)
  4. 3.4 Global Combined Polio Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Combined Polio Vaccine Major Company Production Sites & Headquarters
  6. 3.6 Global Combined Polio Vaccine Company, Product Type & Application
  7. 3.7 Global Combined Polio Vaccine Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Combined Polio Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Combined Polio Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Combined Polio Vaccine Tier 1, Tier 2, and Tier 3
4 Combined Polio Vaccine Regional Status and Outlook
  1. 4.1 Global Combined Polio Vaccine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Combined Polio Vaccine Historic Market Size by Region
  3. 4.2.1 Global Combined Polio Vaccine Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Combined Polio Vaccine Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Combined Polio Vaccine Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Combined Polio Vaccine Forecasted Market Size by Region
  7. 4.3.1 Global Combined Polio Vaccine Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Combined Polio Vaccine Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Combined Polio Vaccine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Combined Polio Vaccine by Application
  1. 5.1 Combined Polio Vaccine Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Combined Polio Vaccine Market Size by Application
  6. 5.2.1 Global Combined Polio Vaccine Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Combined Polio Vaccine Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Combined Polio Vaccine Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Combined Polio Vaccine Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Combined Polio Vaccine Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Combined Polio Vaccine Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Combined Polio Vaccine Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Combined Polio Vaccine Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Sanofi
  2. 6.1.1 Sanofi Company Information
  3. 6.1.2 Sanofi Business Overview
  4. 6.1.3 Sanofi Combined Polio Vaccine Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Sanofi Combined Polio Vaccine Product Portfolio
  6. 6.1.5 Sanofi Recent Developments
  7. 6.2 Merck & Co., Inc.
  8. 6.2.1 Merck & Co., Inc. Company Information
  9. 6.2.2 Merck & Co., Inc. Business Overview
  10. 6.2.3 Merck & Co., Inc. Combined Polio Vaccine Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Merck & Co., Inc. Combined Polio Vaccine Product Portfolio
  12. 6.2.5 Merck & Co., Inc. Recent Developments
  13. 6.3 Panacea Biotec Ltd.
  14. 6.3.1 Panacea Biotec Ltd. Company Information
  15. 6.3.2 Panacea Biotec Ltd. Business Overview
  16. 6.3.3 Panacea Biotec Ltd. Combined Polio Vaccine Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Panacea Biotec Ltd. Combined Polio Vaccine Product Portfolio
  18. 6.3.5 Panacea Biotec Ltd. Recent Developments
  19. 6.4 Mitsubishi Chemical Group Corp.
  20. 6.4.1 Mitsubishi Chemical Group Corp. Company Information
  21. 6.4.2 Mitsubishi Chemical Group Corp. Business Overview
  22. 6.4.3 Mitsubishi Chemical Group Corp. Combined Polio Vaccine Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Mitsubishi Chemical Group Corp. Combined Polio Vaccine Product Portfolio
  24. 6.4.5 Mitsubishi Chemical Group Corp. Recent Developments
  25. 6.5 Meiji Holdings Co., Ltd.
  26. 6.5.1 Meiji Holdings Co., Ltd. Company Information
  27. 6.5.2 Meiji Holdings Co., Ltd. Business Overview
  28. 6.5.3 Meiji Holdings Co., Ltd. Combined Polio Vaccine Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Meiji Holdings Co., Ltd. Combined Polio Vaccine Product Portfolio
  30. 6.5.5 Meiji Holdings Co., Ltd. Recent Developments
  31. 6.6 Boryung Corp.
  32. 6.6.1 Boryung Corp. Company Information
  33. 6.6.2 Boryung Corp. Business Overview
  34. 6.6.3 Boryung Corp. Combined Polio Vaccine Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Boryung Corp. Combined Polio Vaccine Product Portfolio
  36. 6.6.5 Boryung Corp. Recent Developments
7 North America by Country
  1. 7.1 North America Combined Polio Vaccine Sales by Country
  2. 7.1.1 North America Combined Polio Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Combined Polio Vaccine Sales by Country (2021-2026)
  4. 7.1.3 North America Combined Polio Vaccine Sales Forecast by Country (2027-2032)
  5. 7.2 North America Combined Polio Vaccine Market Size by Country
  6. 7.2.1 North America Combined Polio Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Combined Polio Vaccine Market Size by Country (2021-2026)
  8. 7.2.3 North America Combined Polio Vaccine Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Combined Polio Vaccine Sales by Country
  2. 8.1.1 Europe Combined Polio Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Combined Polio Vaccine Sales by Country (2021-2026)
  4. 8.1.3 Europe Combined Polio Vaccine Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Combined Polio Vaccine Market Size by Country
  6. 8.2.1 Europe Combined Polio Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Combined Polio Vaccine Market Size by Country (2021-2026)
  8. 8.2.3 Europe Combined Polio Vaccine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Combined Polio Vaccine Sales by Country
  2. 9.1.1 Asia-Pacific Combined Polio Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Combined Polio Vaccine Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Combined Polio Vaccine Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Combined Polio Vaccine Market Size by Country
  6. 9.2.1 Asia-Pacific Combined Polio Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Combined Polio Vaccine Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Combined Polio Vaccine Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Combined Polio Vaccine Sales by Country
  2. 10.1.1 South America Combined Polio Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Combined Polio Vaccine Sales by Country (2021-2026)
  4. 10.1.3 South America Combined Polio Vaccine Sales Forecast by Country (2027-2032)
  5. 10.2 South America Combined Polio Vaccine Market Size by Country
  6. 10.2.1 South America Combined Polio Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Combined Polio Vaccine Market Size by Country (2021-2026)
  8. 10.2.3 South America Combined Polio Vaccine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Combined Polio Vaccine Sales by Country
  2. 11.1.1 Middle East and Africa Combined Polio Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Combined Polio Vaccine Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Combined Polio Vaccine Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Combined Polio Vaccine Market Size by Country
  6. 11.2.1 Middle East and Africa Combined Polio Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Combined Polio Vaccine Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Combined Polio Vaccine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Combined Polio Vaccine Value Chain Analysis
  2. 12.1.1 Combined Polio Vaccine Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Combined Polio Vaccine Production Mode & Process
  7. 12.2 Combined Polio Vaccine Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Combined Polio Vaccine Distributors
  10. 12.2.3 Combined Polio Vaccine Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst